Rocket Lab USA, Inc. announced via 8-K the filing of a prospectus supplement and entry into an ATM Equity Offering Sales Agreement dated March 11, 2025, with sales agents BofA Securities, Inc., Cantor Fitzgerald & Co., Stifel, Nicolaus & Company, Incorporated, and TD Securities (USA) LLC. Under the agreement, the company may sell shares of common stock with an aggregate offering price of up to $500 million from time to time, acting through the agents or directly as principal. The sales are governed by an effective shelf registration statement on Form S-3 filed March 11, 2025. The agents will use commercially reasonable efforts based on company instructions, subject to customary terms, representations, and warranties. The agreement is terminable by either party at any time upon notice, providing flexible capital access without commitment.

This ATM program offers Rocket Lab flexible, opportunistic access to up to $500M in equity capital to fund growth, such as Neutron rocket development and launch cadence expansion, without immediate dilution or debt incurrence. Near-term, actual sales could pressure stock price due to overhang and dilution concerns, impacting EPS. Strategically significant for liquidity in a capital-intensive space sector; investors should monitor Form 144 or 8-K updates for sales activity and assess valuation amid ongoing cash burn.